Ítem
Acceso Abierto

Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy

Mostrar el registro sencillo de la publicación
dc.contributorPérez, María
dc.contributor.advisorGarzón Olarte, Martín Alonso
dc.creatorSuarez, Oscar
dc.creatorPérez, María
dc.creatorGarzón Olarte, Martín Alonso
dc.creatorDaza, Rodrigo
dc.creatorHernandez, Geovanny
dc.creatorSalinas, Carolina
dc.creatorCeballos, Jorge
dc.creatorDe Leon, Enrique P.
dc.creatorMugnier, Jacqueline
dc.creatorBeltrán, Oscar
dc.creatorVarón, Adriana
dc.creator.degreeEspecialista en Gastroenterologíaspa
dc.creator.degreetypeFull timespa
dc.date.accessioned2019-01-11T22:07:53Z
dc.date.available2019-01-11T22:07:53Z
dc.date.created2018-12-03
dc.date.issued2018
dc.description.abstractFibrolamellar hepatocarcinoma is an infrequent liver tumor, currently considered to be a variant different from hepatocarcinoma. The differences lie in genomic alterations, a greater prevalence of fibrolamellar hepatocarcinoma in young patients, and its lack of association with underlying liver disease. The clinical presentation is unspecific, with symptoms ranging from abdominal pain, malaise, and weight loss to atypical manifestation which include hyperammonemic encephalopathy. We present the case of a 33-year-old woman with no prior medical history who presented with a coma and a diagnosis of inoperable fibrolamellar hepatocarcinoma requiring a cadaver donor transplant. While she was on the waiting list, she received hemofiltration and ammonium benzoate treatment, with progressive improvement in her state of consciousness.eng
dc.description.sponsorshipUNIVERSIDAD DEL ROSARIOspa
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.48713/10336_18871
dc.identifier.urihttp://repository.urosario.edu.co/handle/10336/18871
dc.language.isospa
dc.publisherUniversidad del Rosariospa
dc.publisher.departmentFacultad de Medicinaspa
dc.publisher.programEspecialización en Gastroenterologíaspa
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombiaspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.source.bibliographicCitationH.A.Edmondson,“Differentialdiagnosisoftumorsandtumorlikelesionsofliverininfancyandchildhood,”A.M.A.American JournalofDiseasesofChildren,vol.91,no.2,pp.168–186,1956.spa
dc.source.bibliographicCitationV.Maniaci,B.R.Davidson,K.Rollesetal.,“Fibrolamellarhepatocellularcarcinoma-Prolongedsurvivalwithmultimodality therapy,”European Journal of Surgical Oncology, vol. 35,no. 6, pp.617–621,2009.spa
dc.source.bibliographicCitationM.Torbenson,“FibrolamellarCarcinoma:2012Update,”Scientifica,vol.2012,ArticleID743790,15pages,2012.spa
dc.source.bibliographicCitationE.J.GrossmanandJ.M.Millis,“Livertransplantationfornonhepatocellularcarcinomamalignancy:indications,limitations, andanalysisofthecurrentliterature,”LiverTransplantation,vol. 16,no.8,pp.930–942,2010.spa
dc.source.bibliographicCitationV. Paradis, “Histopathology of hepatocellular carcinoma,” in Multidisciplinary Treatment of Hepatocellular Carcinoma, vol. 190 of Recent Results in Cancer Research, pp. 21–32, Springer, Berlin,Germany,2013.spa
dc.source.bibliographicCitationG. M. Fonseca, A. D. Varella, F. F. Coelho, E. S. Abe, R. B. Dumarco, and P. Herman, “Downstaging and resection after neoadjuvant therapyfor fibrolamellar hepatocellularcarcinoma,”WorldJournalofGastrointestinalSurgery,vol.6,no.6, p.107,2014.spa
dc.source.bibliographicCitationD.Ganeshan,J.Szklaruk,V.Kundra,A.Kaseb,A.Rashid,and K. Elsayes, “Imaging features of fibrolamellar hepatocellular carcinoma,”AmericanJournalofRoentgenology,vol.202,no.3, pp.544–552,2014.spa
dc.source.bibliographicCitationT.Eggert,K.A.McGlynn,A.Duffy,M.P.Manns,T.F.Greten, andS.F.Altekruse,“Fibrolamellarhepatocellularcarcinomain theUSA,2000–2010:adetailedreportonfrequency,treatment andoutcomebasedonthesurveillance,epidemiology,andend Results database,” United European Gastroenterology Journal, vol.1,no.5,pp.351–357,2013.spa
dc.source.bibliographicCitationH.Cornella,C.Alsinet,S.Sayolsetal.,“Uniquegenomicprofile of fibrolamellar hepatocellular carcinoma,” Gastroenterology, vol.148,no.4,pp.806–818.e10,2015.spa
dc.source.bibliographicCitationG. G. Malouf, S. Job, V. Paradis et al., “Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrinesignature,”Hepatology,vol.59,no.6,pp.2228–2237, 2014.spa
dc.source.bibliographicCitationT. Pawlik and K. Lafaro, “Fibrolamellar hepatocellular carcinoma: current clinical perspectives,” Journal of Hepatocellular Carcinoma,p.151.spa
dc.source.bibliographicCitationT. Kanai, T. Takabayashi, Y. Kawano, S. Kuramochi, and N. Miyazawa,“Acaseofpostoperativerecurrenceoffibrolamellar hepatocellular carcinoma with increased vitamin B12 binding capacityinayoungJapanesefemale,”JapaneseJournalofClinical Oncology,vol.34,no.6,pp.346–351,2004.spa
dc.source.bibliographicCitationS. K. Asrani and N. F. Larusso, “Fibrolamellar hepatocellular carcinoma presenting with budd-chiari syndrome, right atrial thrombus, and pulmonary emboli,” Hepatology, vol. 55, no. 3, pp.977-978,2012.spa
dc.source.bibliographicCitationJ.Lloreta,C.Vadell,X.Fabregat,andS.Serrano,“Fibrolamellar hepatictumorwithneurosecretoryfeaturesandsystemicdepositionofAAamyloid,”UltrastructuralPathology,vol.18,no.1-2, pp.287–292,1994.spa
dc.source.bibliographicCitationJ. A. Espinosa, A. Merlo, M.-O. Arafeh, and G. Munene, “An unusualcaseofjaundice:Biliarytumorthrombusinfibrolamellar hepatocellular carcinoma,” International Journal of Surgery CaseReports,vol.36,pp.50–54,2017.spa
dc.source.bibliographicCitationK. M. Tezer, B. Yalc ¸´ın, N. B¨ uy¨ukpamukc¸u, G. Kale, and M. B¨uy¨ukpamukc¸u,“Fibrolamellarhepatocellularcarcinomawith skeletalmetastases,”PediatricHematologyandOncology,vol.18, no.4,pp.273–278,2001.spa
dc.source.bibliographicCitationN.A.Villa,R.Pannala,D.O.Faigeletal.,“Metastaticfibrolamellar hepatocellular carcinoma to the pancreas,” Case Reports in Gastroenterology,vol.9,pp.266–271,2015.spa
dc.source.bibliographicCitationS.H.Ciurea,E.Matei,C.S.Stanescuetal.etal.,“Fibrolamellar hepatocellularcarcinomawithovarianmetastasis-anunusual presentation.Rom,”JournalofMorphologyandEmbryology,vol. 58,pp.187-92,2017.spa
dc.source.bibliographicCitationO.Soreide,A.Czemiak,H.Bradpiece,S.Bloom,andL.Blumgart,“Characteristicsoffibrolamellarhepatocellularcarcinoma. A study of nine cases and a review of the literature,” The AmericanJournalofSurgery,vol.151,no.4,pp.518–523,1986.spa
dc.source.bibliographicCitationD. L. Lildballe, K. Q. T. Nguyen, S. S. Poulsen, H. O. Nielsen, and E. Nexo, “Haptocorrin as marker of disease progression infibrolamellarhepatocellularcarcinoma,”EuropeanJournalof SurgicalOncology,vol.37,no.1,pp.72–79,2011.spa
dc.source.bibliographicCitationR. K. G. Do, A. McErlean, C. S. Ang, R. P. Dematteo, and G. K. Abou-Alfa, “CT and MRI of primary and metastatic fibrolamellar carcinoma: A case series of 37 patients,” British JournalofRadiology,vol.87,no.1040,ArticleID20140024,2014.spa
dc.source.bibliographicCitationS. Liu, K. Wah Chan, J. Tong, Y. Wang, B. Wang, and L. Qiao, “PET-CT scan is a valuable modality in the diagnosis of fibrolamellar hepatocellularcarcinoma:A casereport and a summaryofrecentliterature,”QJM:AnInternationalJournalof Medicine,vol.104,no.6,pp.477–483,2011.spa
dc.source.bibliographicCitationC.G.Roth andD.G.Mitchell,“Hepatocellularcarcinomaand otherhepaticmalignancies:MRimaging,”RadiologicClinicsof NorthAmerica,vol.52,no.4,pp.683–707,2014.spa
dc.source.bibliographicCitationS. Sethi, N. Tageja, J. Singh et al., “Hyperammonemic encephalopathy:Ararepresentationoffibrolamellarhepatocellularcarcinoma,”TheAmericanJournaloftheMedicalSciences , vol.338,no.6,pp.522–524,2009.spa
dc.source.bibliographicCitationC. Berger, P. Dimant, L. Hermida, F. Paulin, M. Pereyra, and M.Tejo,“Hyperammonemicencephalopathyandfibrolamellar hepatocellularcarcinoma,”Medicina(Argentina),vol.72,no.5, pp.425–427,2012.spa
dc.source.bibliographicCitationR. A. Sulaiman and T. Geberhiwot, “Fibrolamellar Hepatocellular Carcinoma Mimicking Ornithine Transcarbamylase Deficiency,”inJIMDReportsVolume16,vol.16ofJIMDReports, pp.47–50,SpringerBerlinHeidelberg,Berlin,Heidelberg,2014.spa
dc.source.bibliographicCitationC. I. Chapuy, I. Sahai, R. Sharma, A. X. Zhu, and O. N. Kozyreva,“Hyperammonemicencephalopathyassociatedwith fibrolamellar hepatocellular carcinoma: Case report, literature review,andproposedtreatmentalgorithm,”TheOncologist,vol. 21,no.4,pp.514–520,2016.spa
dc.source.bibliographicCitationM. N. Mavros, S. C. Mayo, O. Hyder, and T. M. Pawlik, “A systematic review: Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma,” Journal of the AmericanCollegeofSurgeons,vol.215,no.6,pp.820–830,2012.spa
dc.source.bibliographicCitationW. T. Kassahun, “Contemporary management of fibrolamellar hepatocellular carcinoma: Diagnosis, treatment, outcome, prognosticfactors,andrecentdevelopments,”WorldJournalof SurgicalOncology,vol.14,no.1,articleno.151,2016.spa
dc.source.bibliographicCitationA. D. Pinna, S. Iwatsuki, R. G. Lee et al., “Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation,”Hepatology,vol.26,no.4,pp.877–883,1997.spa
dc.source.bibliographicCitationL.G.Atienza,J.Berger,X.Meietal.,“Livertransplantationfor fibrolamellarhepatocellularcarcinoma:Anationalperspective,” JournalofSurgicalOncology,vol.115,no.3,pp.319–323,2017.spa
dc.source.bibliographicCitationA.O.Kaseb,M.Shama,I.H.Sahinetal.,“Prognosticindicators and treatmentoutcome in94 casesof fibrolamellar hepatocellularcarcinoma,”Oncology(Switzerland),vol.85,no.4,pp.197– 203,2013.spa
dc.source.bibliographicCitationB. Njei, “Fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: Better 5-year survival or artifactualresultofresearchmethodology?”Gut,vol.63,no.9, pp.1374-1375,2014spa
dc.source.bibliographicCitationA. E. Alsina, “Successful Liver Transplantation for HyperammonemicFibrolamellarHepatocellularCarcinoma,”ACGCase ReportsJournal,vol.3,no.4,2016spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subjectFibrolamellar hepatocellular carcinomaspa
dc.subjectNoncirrhotic hyperammonemic encephalopathyspa
dc.subject.ddcEnfermedadesspa
dc.subject.lembHepatocarcinoma fibrolamelarspa
dc.subject.lembEnfermedades hepáticasspa
dc.titleFibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathyspa
dc.typemasterThesiseng
dc.type.documentArtículospa
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.type.spaTrabajo de gradospa
Archivos
Bloque original
Mostrando1 - 1 de 1
Miniatura
Nombre:
SuarezSanchez-OscarJavier-2018.pdf
Tamaño:
1.43 MB
Formato:
Adobe Portable Document Format
Descripción:
Documento Principal
Descargar
Colecciones
Especialización en Gastroenterología